Ampicillin

Ampicillin is a medication used to manage and treat certain bacterial infections. It is in the penicillin class of medications. Ampicillin was developed to overcome the issue of drug resistance and extend the antimicrobial coverage of penicillins. It is also resistant to acid so it can be administered orally. This activity outlines the indications, action, and contraindications for ampicillin as a valuable agent in treating certain bacterial infections like those from E. coli, S. aureus, S. pneumoniae, H. influenzae, etc. In addition, this activity will highlight the mechanism of action, adverse event profile, off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, and relevant interactions pertinent for interprofessional team members in treating patients with infections caused by susceptible bacteria.

Copyright © 2024, StatPearls Publishing LLC.

Conflict of interest statement

Disclosure: Basil Peechakara declares no relevant financial relationships with ineligible companies.

Disclosure: Hajira Basit declares no relevant financial relationships with ineligible companies.

Disclosure: Mohit Gupta declares no relevant financial relationships with ineligible companies.

Sections

• Continuing Education Activity
• Indications
• Mechanism of Action
• Administration
• Adverse Effects
• Contraindications
• Monitoring
• Toxicity
• Enhancing Healthcare Team Outcomes
• Review Questions
• References

Similar articles

Gold JM, Raja A. Gold JM, et al. 2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31613475 Free Books & Documents.

Butt I, Kasmin F. Butt I, et al. 2024 Jul 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2024 Jul 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31971721 Free Books & Documents.

Colquhoun M, Kemp AK. Colquhoun M, et al. 2023 Mar 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Mar 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 34033407 Free Books & Documents.

Taylor M, Gerriets V. Taylor M, et al. 2023 May 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 May 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31194337 Free Books & Documents.

Cohen B, Ruth LJ, Preuss CV. Cohen B, et al. 2023 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29083658 Free Books & Documents.

References

1. 1. Kaushik D, Mohan M, Borade DM, Swami OC. Ampicillin: rise fall and resurgence. J Clin Diagn Res. 2014 May;8(5):ME01-3. - PMC - PubMed
   1. Biggs BA, Kucers A. Penicillins and related drugs. Med J Aust. 1986 Dec 1-15;145(11-12):607-11. - PubMed
   1. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA. 1995 Dec 06;274(21):1706-13. - PubMed
   1. Heintz BH, Halilovic J, Christensen CL. Vancomycin-resistant enterococcal urinary tract infections. Pharmacotherapy. 2010 Nov;30(11):1136-49. - PubMed
   1. Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis. 1997 Jan;24 Suppl 1:S106-9. - PubMed